High level mRNA expression of AXL correlated with a shorter colon cancer patient survival time in the GSE14333 cohort, although this correlation was not significant (high level: mean survival = 80 months, 95% CI = 71–88 months; low level: mean survival = 114 months, 95% CI = 101–129 months, p = 0.064; Figure 3A). This evidence concerns the gene AXL and malignant colon neoplasm.